|
Cinfa strengthens mental
health support in the region
with accessible quality
therapies
(MIDDLE EAST)
-
Mental health has emerged as
one of the most pressing
social and healthcare
challenges in the Middle
East.
More than 75% of
mental disorders begin
before the age of
25, underlining the
importance of prevention and
early intervention. In fact,
one in two people worldwide
(50%)
will develop a mental health
disorder by the age of 75,
with a median age of onset
of 19 for men and 20 for
women.
In the
Eastern Mediterranean region,
covering much of MENA,
between 15.6% and 35.5% of
adults experience a mental
disorder, with higher rates
in areas affected by
humanitarian crises.
In the Middle East and North
Africa (MENA), it is
estimated that about one out
of every six adolescents
between 10 and 19 years
old—more than 15 million
individuals—are living with
some form of mental
disorder. Among children
younger than 10,
developmental and behavioral
conditions also represent a
major issue, impacting
roughly
7% of this age group
across the region.
Supporting awareness
and access through local
collaboration
As part of its long-term
commitment to improving
mental health outcomes,
Cinfa is
reinforcing its efforts
across the Gulf region by
addressing key psychiatric
conditions, such as
schizophrenia, bipolar
disorder, and mood
disorders, with tailored,
evidence-based therapies.
According to the Global
Burden of Disease 2019
study,
schizophrenia in the
MENA region affects about
250 people per 100,000
people with an annual
incidence of around 15 new
cases per 100,000.
The company’s approach
prioritizes both
accessibility and clinical
relevance, aligning with
local healthcare priorities.
Cinfa’s therapeutic
portfolio in the region
includes advanced,
scientifically based
treatments for complex
mental health conditions:
-
Olanole
(Olanzapine) is
prescribed for
schizophrenia and
bipolar disorder.
-
Zinole
(Aripiprazole) is used
in various psychiatric
indications, including
schizophrenia and mood
disorders.
Through close collaboration
with local medical
communities, Cinfa seeks to
ensure that its treatments
respond to the specific
needs of each healthcare
system, helping to bridge
therapeutic gaps and
strengthen early
intervention pathways in
mental health care.
Tackling Mental
Health as a Health Priority
in the Middle East
Mental health challenges
have a direct impact on
individual well-being,
family life, productivity,
and long-term healthcare
needs.
According to
the WHO Regional Office for
the Eastern Mediterranean,
there has been progress
towards the global targets
of the
Comprehensive Mental Health
Action Plan in the
region. At the same time,
challenges remain—such as
further integrating mental
health into primary care,
increasing the number of
trained professionals, and
reducing stigma. Addressing
these areas will help
accelerate diagnosis and
treatment, particularly
among youth and underserved
populations, and ultimately
improve clinical outcomes
while reducing economic
burden.
“Mental
health includes emotional,
psychological, and social
well-being; it influences
how we think, feel, and
act,” stated Dr.
Alicia López de Ocáriz,
Corporate Medical Director
at Cinfa. “Early
support can be decisive, and
improving people’s access to
treatment is part of our
long-term commitment in the
region.”
Empowering Clinical
Decision-Making Through
Digital Resources
In addition to its
therapeutic portfolio, the
company continues to
strengthen its digital
platform to provide
healthcare professionals
with updated and useful
tools. The aim is to offer
clinical resources across
different therapeutic areas,
always aligned with official
guidelines, to support daily
medical practice and
contribute to high-quality
patient care.
PRINT
THIS ARTICLE
|
